Neal Masia is Vice President, Global Economics and International Treasury at Pfizer Inc. and is an Adjunct Associate Professor of Economics and Business at Columbia University. He is Pfizer’s chief corporate economist and leads teams in New York, Dublin and Singapore supporting financing activities for the company’s global affiliate network. He plays a significant role in Pfizer’s strategic transactions and major business development activities. Previously, Neal managed investments in Pfizer’s $13 billion pension plan and led Pfizer’s capital markets function, and earlier held roles in public policy and corporate strategy. Prior to joining Pfizer, Neal worked as a strategy consultant, as an economist with the U.S. Congressional Budget Office, in strategy and marketing at a venture-backed technology startup, and as a key health policy advisor on a national Presidential campaign. His teaching at Columbia focuses on public policy and the healthcare industry. He earned a B.A. (High Honors) in Mathematical Economics from Colgate University and Ph.D. in Economics from the University of Rochester, where he specialized in Public Finance and Game Theory.